Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-in Capital [Member]	Comprehensive Loss [Member]	Accumulated Comprehensive Income [Member]	Accumulated Deficit [Member]	Treasury Stock [Member]
Beginning balance at Dec. 31, 2023	$ 8,989,350	$ 2,715	$ 105,840,239		$ 83,669	$ (96,930,809)	$ (6,464)
Beginning balance, shares at Dec. 31, 2023		27,135,061
Beginning balance, shares at Dec. 31, 2023							27
Common stock issued upon vesting of restricted stock units		$ 31	(31)
Common stock issued upon vesting of restricted stock units, Shares		300,544
Proceeds from sale of common stock in public offering, value	4,598,771	$ 135	4,598,636
Proceeds from sale of common stock in public offering, shares		1,354,218
Proceeds from sale of pre-funded warrants, value	$ 763,138		763,138
Exercise of stock options, shares	0
Stock-based compensation	$ 320,288		320,288
Unrealized gains on foreign currency adjustments	63,842			$ 63,842
Net Income (Loss)	(3,835,632)					(3,835,632)
Ending balance at Mar. 31, 2024	10,899,757	$ 2,881	111,522,270	147,511		(100,766,441)	$ (6,464)
Ending balance, shares at Mar. 31, 2024		28,789,823
Ending balance, shares at Mar. 31, 2024							27
Beginning balance at Dec. 31, 2024	$ 24,714,057	$ 3,439	127,846,026	(14,406)		(103,114,538)	$ (6,464)
Beginning balance, shares at Dec. 31, 2024		34,378,297
Beginning balance, shares at Dec. 31, 2024	27						27
Common stock issued upon vesting of restricted stock units		$ 7	(7)
Common stock issued upon vesting of restricted stock units, Shares		59,031
Common stock issued upon vesting of incentive stock options, Share		708
Exercise of stock options, shares	0
Stock-based compensation	$ 540,204		540,204
Unrealized gains on foreign currency adjustments	(102,139)			(102,139)
Net Income (Loss)	(3,465,058)					(3,465,058)
Ending balance at Mar. 31, 2025	$ 21,687,064	$ 3,446	$ 128,386,223	$ (116,545)		$ (106,579,596)	$ (6,464)
Ending balance, shares at Mar. 31, 2025		34,438,036
Ending balance, shares at Mar. 31, 2025	27						27